Related Experiment Videos
Central serous chorioretinopathy associated with administration of sympathomimetic agents
John C Michael1, John Pak, Jose Pulido
1Retina Institute of Illinois, Niles, Illinois 60714, USA. johnmichael@aol.com
Purpose:
To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity.
Design:
Observational case series.
Methods:
Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties.
Results:
In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication.
Conclusions:
Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.